Progress in the use of microarray technology to study the neurobiology of disease

Nature Neuroscience

Volumn 7, Issue 5, 2004, Pages 434-439

  Mirnics, Károly ^a   Pevsner, Jonathan ^b,c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b KENNEDY KRIEGER INSTITUTE   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; RNA;

BRAIN DISEASE; BRAIN FUNCTION; BRAIN NERVE CELL; BRAIN REGION; BRAIN TISSUE; CADAVER; DATA ANALYSIS; DNA MICROARRAY; ENVIRONMENTAL FACTOR; FROZEN SECTION; GENE CONSTRUCT; GENE CONTROL; GENE EXPRESSION PROFILING; GENE MUTATION; GENOME ANALYSIS; GENOTYPE PHENOTYPE CORRELATION; GLIA CELL; HEREDITY; HUMAN; MEDICAL TECHNOLOGY; MOLECULAR BIOLOGY; NEUROBIOLOGY; PATHOPHYSIOLOGY; PREFRONTAL CORTEX; PRIORITY JOURNAL; REVIEW; SAMPLE SIZE;

ANIMALS; BRAIN; COOPERATIVE BEHAVIOR; DATABASES, FACTUAL; GENE EXPRESSION PROFILING; HUMANS; NERVOUS SYSTEM DISEASES; NEUROBIOLOGY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POSTMORTEM CHANGES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STATISTICS; TRANSCRIPTION, GENETIC;

EID: 2142757232     PISSN: 10976256     EISSN: None     Source Type: Journal    
DOI: 10.1038/nn1230     Document Type: Review

References (65)

1. Schena, M., Shalon, D., Davis, R.W. & Brown, P.O. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270, 467-470 (1995).
2. Lockhart, D.J. et al. Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat. Biotechnol. 14, 1675-1680 (1996).
3. Cheung, V.G. et al. Making and reading microarrays. Nat. Genet. 21, 15-19 (1999).
4. Hoffman, E. et al. Guidelines: Expression profiling - best practices for data generation and interpretation in clinical trials. Nat. Rev. Genet. 5, 229-237 (2004).
5. Stuart, J.M., Segal, E., Koller, D. & Kim, S.K. A gene-coexpression network for global discovery of conserved genetic modules. Science 302, 249-255 (2003).
6. Blalock, E.M. et al. Incipient Alzheimer's disease: Microarray correlation analyses reveal major transcriptional and tumor suppressor responses. Proc. Natl. Acad. Sci. USA 101, 2173-2178 (2004).
7. Mirnics, K., Middleton, F.A., Lewis, D.A. & Levitt, P. Analysis of complex brain disorders with gene expression microarrays: schizophrenia as a disease of the synapse. Trends Neurosci. 24, 479-486 (2001).
8. Mirnics, K. Microarrays in brain research: the good, the bad and the ugly. Nat. Rev. Neurosci. 2, 444-447 (2001).
9. Colantuoni, C. et al. Gene expression profiling in postmortem Rett Syndrome brain: differential gene expression and patient classification. Neurobiol. Dis. 8, 847-865 (2001).
10. Pongrac, J., Middleton, F.A., Lewis, D.A., Levitt, P. & Mirnics, K. Gene expression profiling with DNA microarrays: advancing our understanding of psychiatric disorders. Neurochem. Res. 27, 1049-1063 (2002).
11. Greenbaum, D., Colangelo, C., Williams, K. & Gerstein, M. Comparing protein abundance and mRNA expression levels on a genomic scale. Genome Biol. 4, 117 (2003).
12. Pierri, J.N., Chaudry, A.S., Woo, T.U. & Lewis, D.A. Alterations in chandelier neuron axon terminals in the prefrontal cortex of schizophrenic subjects. Am. J. Psychiatry 156, 1709-1179 (1999).
13. Lewis, D.A. & Levitt, P. Schizophrenia as a disorder of neurodevelopment. Annu. Rev. Neurosci. 25, 409-432 (2002).
14. Lewis, D.A. The human brain revisited: opportunities and challenges in postmortem studies of psychiatric disorders. Neuropsychopharmacology 26, 143-154 (2002).
15. Harrison, P.J. et al. The relative importance of premortem acidosis and postmortem interval for human brain gene expression studies: selective mRNA vulnerability and comparison with their encoded proteins. Neurosci. Lett. 200, 151-154 (1995).
16. Quackenbush, J. Microarray data normalization and transformation. Nat. Genet. 32 (Suppl.), 496-501 (2002).
17. Smyth, G. & Speed, T. Normalization of cDNA microarray data. Methods 31, 265-273 (2003).
18. Tusher, V.G., Tibshirani, R. & Chu, G. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. USA 98, 5116-5121 (2001).
19. Li, C. & Hung Wong, W. Model-based analysis of oligonucleotide arrays: model validation, design issues and standard error application. Genome Biol. 2, 32.1-32.11 (2001).
20. Eisen, M.B., Spellman, P.T., Brown, P.O. & Botstein, D. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. USA 95, 14863-14868 (1998).
21. Kerr, M.K. & Churchill, G.A. Bootstrapping cluster analysis: assessing the reliability of conclusions from microarray experiments. Proc. Natl. Acad. Sci. USA 98, 8961-8965 (2001).
22. Alizadeh, A.A. et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403, 503-511 (2000).
23. Evans, S.J. et al. DNA microarray analysis of functionally discrete human brain regions reveals divergent transcriptional profiles. Neurobiol. Dis. 14, 240-250 (2003).
24. Mukasa, A. et al. Distinction in gene expression profiles of oligodendrogliomas with and without allelic loss of 1p. Oncogene 21, 3961-3968 (2002).
25. Mirnics, K., Middleton, F.A., Marquez, A., Lewis, D.A. & Levitt, P. Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron 28, 53-67 (2000).
26. Hemby, S.E. et al. Gene expression profile for schizophrenia: discrete neuron transcription patterns in the entorhinal cortex. Arch. Gen. Psychiatry 59, 631-640 (2002).
27. Middleton, F.A., Mirnics, K., Pierri, J.N., Lewis, D.A. & Levitt, P. Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia. J. Neurosci. 22, 2718-2729 (2002).
28. Vawter, M.P. et al. Microarray analysis of gene expression in the prefrontal cortex in schizophrenia: a preliminary study. Schizophr. Res. 58, 11-20 (2002).
29. Tkachev, D. et al. Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet 362, 798-805 (2003).
30. Mimmack, M.L. et al. Gene expression analysis in schizophrenia: reproducible upregulation of several members of the apolipoprotein L family located in a high-susceptibility locus for schizophrenia on chromosome 22. Proc. Natl. Acad. Sci. USA 99, 4680-4685 (2002).
31. Hakak, Y. et al. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc. Natl. Acad. Sci. USA 98, 4746-4751 (2001).
32. Mirnics, K., Middleton, F.A., Stanwood, G.D., Lewis, D.A. & Levitt, P. Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia. Mol. Psychiatry 6, 293-301 (2001).
33. Chowdari, K.V. et al. Association and linkage analyses of RGS4 polymorphisms in schizophrenia. Hum. Mol. Genet. 11, 1373-1380 (2002).
34. Williams, N.M. et al. Support for RGS4 as a susceptibility gene for schizophrenia. Biol. Psychiatry 55, 192-195 (2004).
35. Morris, D.W. et al. Confirming RGS4 as a susceptibility gene for schizophrenia. Am. J. Med. Genet. 125, 50-53 (2004).
36. Lewohl, J.M. et al. Gene expression in human alcoholism: microarray analysis of frontal cortex. Alcohol Clin. Exp. Res. 24, 1873-1882 (2000).
37. Lewohl, J.M., Dodd, P.R., Mayfield, R.D. & Harris, R.A. Application of DNA microarrays to study human alcoholism. J. Biomed. Sci. 8, 28-36 (2001).
38. Albertson, D. et al. Gene expression profile of the nucleus accumbens of human cocaine abusers: evidence for dysregulation of myelin. J Neurochem. 88, 1211-1219 (2004).
39. Traynor, J., Agarwal, P., Lazzeroni, L. & Francke, U. Gene expression patterns vary in clonal cell cultures from Rett syndrome females with eight different MECP2 mutations. BMC Med. Genet. 3, 12 (2002).
40. Tudor, M., Akbarian, S., Chen, R.Z. & Jaenisch, R. Transcriptional profiling of a mouse model for Rett syndrome reveals subtle transcriptional changes in the brain. Proc. Natl. Acad. Sci. USA 99, 15536-15541 (2002).
41. Mycko, M.P., Papoian, R., Boschert, U., Raine, C.S. & Selmaj, K.W. cDNA microarray analysis in multiple sclerosis lesions: detection of genes associated with disease activity. Brain 126, 1048-1057 (2003).
42. Whitney, L.W. et al. Analysis of gene expression in mutiple sclerosis lesions using cDNA microarrays. Ann. Neurol. 46, 425-428 (1999).
43. Whitney, L.W., Ludwin, S.K., McFarland, H.F. & Biddison, W.E. Microarray analysis of gene expression in multiple sclerosis and EAE identifies 5-lipoxygenase as a component of inflammatory lesions. J. Neuroimmunol 121, 40-48 (2001).
44. Lock, C. et al. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat. Med. 8, 500-508 (2002).
45. Marcotte, E.R., Srivastava, L.K. & Quirion, R. cDNA microarray and proteomic approaches in the study of brain diseases: focus on schizophrenia and Alzheimer's disease. Pharmacol. Ther. 100, 63-74 (2003).
46. Colangelo, V. et al. Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: transcription and neurotrophic factor down-regulation and up-regulation of apoptotic and pro-inflammatory signaling. J. Neurosci. Res. 70, 462-473 (2002).
47. Loring, J.F., Wen, X., Lee, J.M., Seilhamer, J. & Somogyi, R. A gene expression profile of Alzheimer's disease. DNA Cell. Biol. 20, 683-695 (2001).
48. Mufson, E.J., Counts, S.E. & Ginsberg, S.D. Gene expression profiles of cholinergic nucleus basalis neurons in Alzheimer's disease. Neurochem. Res. 27, 1035-1048 (2002).
49. Ginsberg, S.D. et al. Predominance of neuronal mRNAs in individual Alzheimer's disease senile plaques. Ann. Neurol. 45, 174-181 (1999).
50. Ginsberg, S.D., Hemby, S.E., Lee, V.M., Eberwine, J.H. & Trojanowski, J.Q. Expression profile of transcripts in Alzheimer's disease tangle-bearing CA1 neurons. Ann. Neurol. 48, 77-87 (2000).
51. Yao, P.J. et al. Defects in expression of genes related to synaptic vesicle trafficking in frontal cortex of Alzheimer's disease. Neurobiol. Dis. 12, 97-109 (2003).
52. Pasinetti, G.M. Use of cDNA microarray in the search for molecular markers involved in the onset of Alzheimer's disease dementia. J. Neurosci. Res. 65, 471-476 (2001).
53. Mao, R., Zielke, C.L., Zielke, H.R. & Pevsner, J. Global up-regulation of chromosome 21 gene expression in the developing Down syndrome brain. Genomics 81, 457-467 (2003).
54. Pollack, J.R. et al. Genome-wide analysis of DNA copy-number changes using cDNA microarrays. Nat. Genet. 23, 41-46 (1999).
55. Hirose, Y. et al. Grade II astrocytomas are subgrouped by chromosome aberrations. Cancer Genet. Cytogenet 142, 1-7 (2003).
56. Edgar, R., Domrachev, M. & Lash, A.E. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 30, 207-210 (2002).
57. Brooksbank, C. et al. The European Bioinformatics Institute's data resources. Nucleic Acids Res. 31, 43-50 (2003).
58. Brazma, A. et al. Array Express-a public repository for microarray gene expression data at the EBI. Nucleic Acids Res. 31, 68-71 (2003).
59. Brazma, A. et al. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat. Genet. 29, 365-371 (2001).
60. Causton, H.C. & Game, L. MGED comes of age. Genome Biol. 4, 351 (2003).
61. Mimmack, M.L. & Bahn, S. Quantitative RT-PCR in brain research. Biol. Psychiatry (in press).
62. Watase, K. & Zoghbi, H.Y. Modelling brain diseases in mice: the challenges of design and analysis. Nat. Rev. Genet. 4, 296-307 (2003).
63. Fell, A. The disordered mind. UC Davis Magazine Online 19 (1), 2001. (http://www-ucdmag.ucdavis.edu/fall01/feature_1.html).
64. Torrey, E.F., Webster, M., Knable, M., Johnston, N. & Yolken, R.H. The stanley foundation brain collection and neuropathology consortium. Schizophr. Res. 44, 151-155 (2000).
65. Pickett, J. Current investigations in autism brain tissue research. J. Autism Dev. Disord. 31, 521-527 (2001).